Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Forkhead box protein S1 (FOXS1) is a DNA-binding transcription factor of the forkhead box (FOX) family characterized by a winged helix domain, encoded by an intronless gene and expressed most prominently in the aorta and kidney. FOXS1 is a context-dependent regulator of gene expression, acting as a transcriptional repressor and modulator of cellular proliferation, migration, epithelial–mesenchymal transition, and differentiation; its role varies by tissue and cancer type, functioning as both an oncogene and a tumor suppressor in different settings. FOXS1 participates in key signaling pathways, influences the tumor immune environment, and is implicated in carcinogenesis, fibrosis, and vascular organization. There are no approved drugs directly targeting FOXS1, but altered FOXS1 expression is associated with several disease states and may serve as a prognostic marker for cancer progression and immune landscape.
Not applicable (no direct-targeting drugs reported); altered expression modulates multiple oncogenic and immunoregulatory pathways including FAK/PI3K/AKT, Hedgehog/GLI1, NF-κB, miRNA, Wnt/β-catenin, TGF-β/SMAD signaling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Forkhead box protein S1 (FOXS1).